NCT04997772View on ClinicalTrials.gov

Digital Health Platform Customized for Patients With Gaucher Disease

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

February 28, 2024

Study Completion Date

March 30, 2024

Conditions
Gaucher DiseasePatient Reported Outcome
Interventions
DEVICE

Digital Gaucher Platform

Digital platform specified for Gaucher patients.

Trial Locations (1)

9103102

Shaare Zedek Medical Center, Jerusalem

All Listed Sponsors
collaborator

Genzyme, a Sanofi Company

INDUSTRY

lead

Shoshana Vilk

OTHER